Proactiveinvestors USA & Canada Genprex, Inc. https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Genprex, Inc. RSS feed en Fri, 03 Jul 2020 23:07:47 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Genprex reveals slew of recent milestones as it plans for upcoming clinical trials https://www.proactiveinvestors.com/companies/news/923341/genprex-reveals-slew-of-recent-milestones-as-it-plans-for-upcoming-clinical-trials-923341.html Thu, 02 Jul 2020 21:16:00 -0400 https://www.proactiveinvestors.com/companies/news/923341/genprex-reveals-slew-of-recent-milestones-as-it-plans-for-upcoming-clinical-trials-923341.html Genprex gets generic name approval for non-small cell lung cancer drug https://www.proactiveinvestors.com/companies/news/922773/genprex-gets-generic-name-approval-for-non-small-cell-lung-cancer-drug-922773.html Thu, 25 Jun 2020 13:15:00 -0400 https://www.proactiveinvestors.com/companies/news/922773/genprex-gets-generic-name-approval-for-non-small-cell-lung-cancer-drug-922773.html Genprex ramps up production of active agent for its lung cancer drug Oncoprex https://www.proactiveinvestors.com/companies/news/922040/genprex-ramps-up-production-of-active-agent-for-its-lung-cancer-drug-oncoprex-922040.html Tue, 16 Jun 2020 13:50:00 -0400 https://www.proactiveinvestors.com/companies/news/922040/genprex-ramps-up-production-of-active-agent-for-its-lung-cancer-drug-oncoprex-922040.html Genprex get set to join elite group of companies on the Russell 3000 Index https://www.proactiveinvestors.com/companies/news/921490/genprex-get-set-to-join-elite-group-of-companies-on-the-russell-3000-index-921490.html Tue, 09 Jun 2020 13:55:00 -0400 https://www.proactiveinvestors.com/companies/news/921490/genprex-get-set-to-join-elite-group-of-companies-on-the-russell-3000-index-921490.html Genprex receives $2.5 million from warrant exercises as it moves towards clinical trials https://www.proactiveinvestors.com/companies/news/920637/genprex-receives-25-million-from-warrant-exercises-as-it-moves-towards-clinical-trials-920637.html Thu, 28 May 2020 13:15:00 -0400 https://www.proactiveinvestors.com/companies/news/920637/genprex-receives-25-million-from-warrant-exercises-as-it-moves-towards-clinical-trials-920637.html Genprex gene therapy candidate Oncoprex fast-tracking for non-small cell lung cancer treatment https://www.proactiveinvestors.com/companies/news/900558/genprex-gene-therapy-candidate-oncoprex-fast-tracking-for-non-small-cell-lung-cancer-treatment-900558.html Wed, 27 May 2020 10:00:00 -0400 https://www.proactiveinvestors.com/companies/news/900558/genprex-gene-therapy-candidate-oncoprex-fast-tracking-for-non-small-cell-lung-cancer-treatment-900558.html Genprex shares rise after Noble Capital Markets repeats Outperform rating, $5 price target https://www.proactiveinvestors.com/companies/news/920444/genprex-shares-rise-after-noble-capital-markets-repeats-outperform-rating-5-price-target-920444.html Tue, 26 May 2020 18:27:00 -0400 https://www.proactiveinvestors.com/companies/news/920444/genprex-shares-rise-after-noble-capital-markets-repeats-outperform-rating-5-price-target-920444.html Genprex forms global licensing deal with MD Anderson for its cancer drug Oncoprex https://www.proactiveinvestors.com/companies/news/919638/genprex-forms-global-licensing-deal-with-md-anderson-for-its-cancer-drug-oncoprex-919638.html Thu, 14 May 2020 19:19:00 -0400 https://www.proactiveinvestors.com/companies/news/919638/genprex-forms-global-licensing-deal-with-md-anderson-for-its-cancer-drug-oncoprex-919638.html Genprex shares soar as it strikes new worldwide license deal with MD Anderson for Oncoprex https://www.proactiveinvestors.com/companies/news/918873/genprex-shares-soar-as-it-strikes-new-worldwide-license-deal-with-md-anderson-for-oncoprex-918873.html Tue, 05 May 2020 18:37:00 -0400 https://www.proactiveinvestors.com/companies/news/918873/genprex-shares-soar-as-it-strikes-new-worldwide-license-deal-with-md-anderson-for-oncoprex-918873.html Genprex CEO Rodney Varner says company’s near-term future 'could be transformational' https://www.proactiveinvestors.com/companies/news/918767/genprex-ceo-rodney-varner-says-companys-near-term-future--could-be-transformational--918767.html Mon, 04 May 2020 15:37:00 -0400 https://www.proactiveinvestors.com/companies/news/918767/genprex-ceo-rodney-varner-says-companys-near-term-future--could-be-transformational--918767.html Genprex taps Shannon Inman as vice president of global clinical operations https://www.proactiveinvestors.com/companies/news/917766/genprex-taps-shannon-inman-as-vice-president-of-global-clinical-operations-917766.html Tue, 21 Apr 2020 14:05:00 -0400 https://www.proactiveinvestors.com/companies/news/917766/genprex-taps-shannon-inman-as-vice-president-of-global-clinical-operations-917766.html Genprex makes key hires to its board and executive team https://www.proactiveinvestors.com/companies/news/916024/genprex-makes-key-hires-to-its-board-and-executive-team-916024.html Fri, 27 Mar 2020 18:48:00 -0400 https://www.proactiveinvestors.com/companies/news/916024/genprex-makes-key-hires-to-its-board-and-executive-team-916024.html Genprex boosts board with three biotechnology and healthcare industry leaders https://www.proactiveinvestors.com/companies/news/915671/genprex-boosts-board-with-three-biotechnology-and-healthcare-industry-leaders-915671.html Tue, 24 Mar 2020 14:00:00 -0400 https://www.proactiveinvestors.com/companies/news/915671/genprex-boosts-board-with-three-biotechnology-and-healthcare-industry-leaders-915671.html Genprex hires two accomplished life science executives as it advances strategic plan https://www.proactiveinvestors.com/companies/news/915541/genprex-hires-two-accomplished-life-science-executives-as-it-advances-strategic-plan-915541.html Mon, 23 Mar 2020 14:10:00 -0400 https://www.proactiveinvestors.com/companies/news/915541/genprex-hires-two-accomplished-life-science-executives-as-it-advances-strategic-plan-915541.html Genprex's newly licensed type 1 diabetes gene therapy's potential explained by scientist https://www.proactiveinvestors.com/companies/news/914306/genprex-s-newly-licensed-type-1-diabetes-gene-therapy-s-potential-explained-by-scientist-914306.html Wed, 04 Mar 2020 12:39:00 -0500 https://www.proactiveinvestors.com/companies/news/914306/genprex-s-newly-licensed-type-1-diabetes-gene-therapy-s-potential-explained-by-scientist-914306.html Genprex secures $17.5M at-the-market offering to fund Oncoprex drug development https://www.proactiveinvestors.com/companies/news/913550/genprex-secures-175m-at-the-market-offering-to-fund-oncoprex-drug-development-913550.html Mon, 24 Feb 2020 14:57:00 -0500 https://www.proactiveinvestors.com/companies/news/913550/genprex-secures-175m-at-the-market-offering-to-fund-oncoprex-drug-development-913550.html CEO Rodney Varner sees newly licensed therapy as an 'opportunity we couldn't pass up' https://www.proactiveinvestors.com/companies/news/913008/ceo-rodney-varner-sees-newly-licensed-therapy-as-an--opportunity-we-couldn-t-pass-up--913008.html Fri, 14 Feb 2020 18:27:00 -0500 https://www.proactiveinvestors.com/companies/news/913008/ceo-rodney-varner-sees-newly-licensed-therapy-as-an--opportunity-we-couldn-t-pass-up--913008.html Genprex inks license agreement with university researchers for potentially curative diabetes gene therapy https://www.proactiveinvestors.com/companies/news/912676/genprex-inks-license-agreement-with-university-researchers-for-potentially-curative-diabetes-gene-therapy-912676.html Tue, 11 Feb 2020 14:49:00 -0500 https://www.proactiveinvestors.com/companies/news/912676/genprex-inks-license-agreement-with-university-researchers-for-potentially-curative-diabetes-gene-therapy-912676.html Genprex prioritizing Oncoprex development in combo with AstraZeneca’s Tagrisso to treat non-small cell lung cancer https://www.proactiveinvestors.com/companies/news/912270/genprex-prioritizing-oncoprex-development-in-combo-with-astrazenecas-tagrisso-to-treat-non-small-cell-lung-cancer-912270.html Wed, 05 Feb 2020 15:33:00 -0500 https://www.proactiveinvestors.com/companies/news/912270/genprex-prioritizing-oncoprex-development-in-combo-with-astrazenecas-tagrisso-to-treat-non-small-cell-lung-cancer-912270.html Genprex's tumor suppressor gene TUSC2 is a novel target and biomarker for thyroid cancer therapy, finds researchers https://www.proactiveinvestors.com/companies/news/911772/genprex-s-tumor-suppressor-gene-tusc2-is-a-novel-target-and-biomarker-for-thyroid-cancer-therapy-finds-researchers-911772.html Wed, 29 Jan 2020 15:09:00 -0500 https://www.proactiveinvestors.com/companies/news/911772/genprex-s-tumor-suppressor-gene-tusc2-is-a-novel-target-and-biomarker-for-thyroid-cancer-therapy-finds-researchers-911772.html Genprex closes on $8M at-the-market stock offering https://www.proactiveinvestors.com/companies/news/911673/genprex-closes-on-8m-at-the-market-stock-offering-911673.html Tue, 28 Jan 2020 14:38:00 -0500 https://www.proactiveinvestors.com/companies/news/911673/genprex-closes-on-8m-at-the-market-stock-offering-911673.html Genprex gets FDA Fast Track for its Oncoprex combination therapy, raises $8M https://www.proactiveinvestors.com/companies/news/911504/genprex-gets-fda-fast-track-for-its-oncoprex-combination-therapy-raises-8m-911504.html Fri, 24 Jan 2020 20:10:00 -0500 https://www.proactiveinvestors.com/companies/news/911504/genprex-gets-fda-fast-track-for-its-oncoprex-combination-therapy-raises-8m-911504.html Genprex rakes in $8M in at-the-market stock offering https://www.proactiveinvestors.com/companies/news/911401/genprex-rakes-in-8m-in-at-the-market-stock-offering-911401.html Thu, 23 Jan 2020 15:10:00 -0500 https://www.proactiveinvestors.com/companies/news/911401/genprex-rakes-in-8m-in-at-the-market-stock-offering-911401.html Genprex wins FDA Fast Track status for its Oncoprex therapy in combination with AstraZeneca's Tagrisso https://www.proactiveinvestors.com/companies/news/911161/genprex-wins-fda-fast-track-status-for-its-oncoprex-therapy-in-combination-with-astrazeneca-s-tagrisso-911161.html Tue, 21 Jan 2020 15:14:00 -0500 https://www.proactiveinvestors.com/companies/news/911161/genprex-wins-fda-fast-track-status-for-its-oncoprex-therapy-in-combination-with-astrazeneca-s-tagrisso-911161.html Genprex reveals positive preclinical data that shows synergies to fight lung cancers https://www.proactiveinvestors.com/companies/news/907770/genprex-reveals-positive-preclinical-data-that-shows-synergies-to-fight-lung-cancers-907770.html Mon, 25 Nov 2019 15:09:00 -0500 https://www.proactiveinvestors.com/companies/news/907770/genprex-reveals-positive-preclinical-data-that-shows-synergies-to-fight-lung-cancers-907770.html Genprex reports positive preclinical data on treating resistant metastatic lung cancers https://www.proactiveinvestors.com/companies/news/907374/genprex-reports-positive-preclinical-data-on-treating-resistant-metastatic-lung-cancers-907374.html Tue, 19 Nov 2019 14:17:00 -0500 https://www.proactiveinvestors.com/companies/news/907374/genprex-reports-positive-preclinical-data-on-treating-resistant-metastatic-lung-cancers-907374.html Genprex believes in non-viral delivery as the next evolution in gene therapy, and scientific paper agrees https://www.proactiveinvestors.com/companies/news/904299/genprex-believes-in-non-viral-delivery-as-the-next-evolution-in-gene-therapy-and-scientific-paper-agrees-904299.html Mon, 07 Oct 2019 14:40:00 -0400 https://www.proactiveinvestors.com/companies/news/904299/genprex-believes-in-non-viral-delivery-as-the-next-evolution-in-gene-therapy-and-scientific-paper-agrees-904299.html Genprex's active drug ingredient validated by independent medical journal 'Nature Medicine' https://www.proactiveinvestors.com/companies/news/903155/genprex-s-active-drug-ingredient-validated-by-independent-medical-journal--nature-medicine--903155.html Fri, 20 Sep 2019 12:30:00 -0400 https://www.proactiveinvestors.com/companies/news/903155/genprex-s-active-drug-ingredient-validated-by-independent-medical-journal--nature-medicine--903155.html Genprex's active drug ingredient shown to prevent tumors, according to medical journal https://www.proactiveinvestors.com/companies/news/902492/genprex-s-active-drug-ingredient-shown-to-prevent-tumors-according-to-medical-journal-902492.html Wed, 11 Sep 2019 14:51:00 -0400 https://www.proactiveinvestors.com/companies/news/902492/genprex-s-active-drug-ingredient-shown-to-prevent-tumors-according-to-medical-journal-902492.html Genprex unveils anticipated milestones, future guidance on the clinical development programs for its Oncoprex immunogene therapy https://www.proactiveinvestors.com/companies/news/901940/genprex-unveils-anticipated-milestones-future-guidance-on-the-clinical-development-programs-for-its-oncoprex-immunogene-therapy-901940.html Tue, 03 Sep 2019 13:05:00 -0400 https://www.proactiveinvestors.com/companies/news/901940/genprex-unveils-anticipated-milestones-future-guidance-on-the-clinical-development-programs-for-its-oncoprex-immunogene-therapy-901940.html Genprex boss Rodney Varner trumpets gene therapy company’s recent achievements https://www.proactiveinvestors.com/companies/news/900651/genprex-boss-rodney-varner-trumpets-gene-therapy-companys-recent-achievements-900651.html Tue, 13 Aug 2019 13:25:00 -0400 https://www.proactiveinvestors.com/companies/news/900651/genprex-boss-rodney-varner-trumpets-gene-therapy-companys-recent-achievements-900651.html Genprex says partner successfully completes manufacturing of TUSC2 plasmid DNA for Oncoprex gene therapy treatment https://www.proactiveinvestors.com/companies/news/900218/genprex-says-partner-successfully-completes-manufacturing-of-tusc2-plasmid-dna-for-oncoprex-gene-therapy-treatment-900218.html Tue, 06 Aug 2019 13:00:00 -0400 https://www.proactiveinvestors.com/companies/news/900218/genprex-says-partner-successfully-completes-manufacturing-of-tusc2-plasmid-dna-for-oncoprex-gene-therapy-treatment-900218.html Genprex Inc making progress on branding for its lead cancer therapy, Oncoprex https://www.proactiveinvestors.com/companies/news/900214/genprex-inc-making-progress-on-branding-for-its-lead-cancer-therapy-oncoprex-900214.html Tue, 06 Aug 2019 12:35:00 -0400 https://www.proactiveinvestors.com/companies/news/900214/genprex-inc-making-progress-on-branding-for-its-lead-cancer-therapy-oncoprex-900214.html Genprex Inc initiates first phase of branding for its lead drug candidate, Oncoprex immunogene therapy https://www.proactiveinvestors.com/companies/news/224805/genprex-inc-initiates-first-phase-of-branding-for-its-lead-drug-candidate-oncoprex-immunogene-therapy-224805.html Wed, 31 Jul 2019 14:15:00 -0400 https://www.proactiveinvestors.com/companies/news/224805/genprex-inc-initiates-first-phase-of-branding-for-its-lead-drug-candidate-oncoprex-immunogene-therapy-224805.html Genprex updates on positive results for its lung cancer drug Oncoprex https://www.proactiveinvestors.com/companies/news/314046/genprex-updates-on-positive-results-for-its-lung-cancer-drug-oncoprex-14046.html Wed, 10 Jul 2019 16:34:00 -0400 https://www.proactiveinvestors.com/companies/news/314046/genprex-updates-on-positive-results-for-its-lung-cancer-drug-oncoprex-14046.html Genprex issues development updates for lung-cancer drug Oncoprex https://www.proactiveinvestors.com/companies/news/223148/genprex-issues-development-updates-for-lung-cancer-drug-oncoprex-223148.html Mon, 01 Jul 2019 13:54:00 -0400 https://www.proactiveinvestors.com/companies/news/223148/genprex-issues-development-updates-for-lung-cancer-drug-oncoprex-223148.html Genprex retains pharma branding agency to select a name for its lead drug https://www.proactiveinvestors.com/companies/news/313350/genprex-retains-pharma-branding-agency-to-select-a-name-for-its-lead-drug-13350.html Tue, 14 May 2019 20:27:00 -0400 https://www.proactiveinvestors.com/companies/news/313350/genprex-retains-pharma-branding-agency-to-select-a-name-for-its-lead-drug-13350.html Genprex Inc retains pharmaceutical branding company to commercialize its lung cancer drug https://www.proactiveinvestors.com/companies/news/219893/genprex-inc-retains-pharmaceutical-branding-company-to-commercialize-its-lung-cancer-drug-219893.html Wed, 08 May 2019 13:29:00 -0400 https://www.proactiveinvestors.com/companies/news/219893/genprex-inc-retains-pharmaceutical-branding-company-to-commercialize-its-lung-cancer-drug-219893.html Genprex reports positive preclinical data on its drug to treat lung cancer https://www.proactiveinvestors.com/companies/news/313161/genprex-reports-positive-preclinical-data-on-its-drug-to-treat-lung-cancer-13161.html Tue, 30 Apr 2019 19:21:00 -0400 https://www.proactiveinvestors.com/companies/news/313161/genprex-reports-positive-preclinical-data-on-its-drug-to-treat-lung-cancer-13161.html Genprex collaborators share positive pre-clinical data linked to Oncoprex at American Association of Cancer Research meeting https://www.proactiveinvestors.com/companies/news/218170/genprex-collaborators-share-positive-pre-clinical-data-linked-to-oncoprex-at-american-association-of-cancer-research-meeting-218170.html Mon, 08 Apr 2019 15:50:00 -0400 https://www.proactiveinvestors.com/companies/news/218170/genprex-collaborators-share-positive-pre-clinical-data-linked-to-oncoprex-at-american-association-of-cancer-research-meeting-218170.html Genprex shares rise after CEO forecasts 2019 will be a landmark one for the gene-therapy company https://www.proactiveinvestors.com/companies/news/217663/genprex-shares-rise-after-ceo-forecasts-2019-will-be-a-landmark-one-for-the-gene-therapy-company-217663.html Mon, 01 Apr 2019 14:20:00 -0400 https://www.proactiveinvestors.com/companies/news/217663/genprex-shares-rise-after-ceo-forecasts-2019-will-be-a-landmark-one-for-the-gene-therapy-company-217663.html Genprex boosts management team with two key hires https://www.proactiveinvestors.com/companies/news/215449/genprex-boosts-management-team-with-two-key-hires-215449.html Wed, 27 Feb 2019 17:25:00 -0500 https://www.proactiveinvestors.com/companies/news/215449/genprex-boosts-management-team-with-two-key-hires-215449.html Genprex adds pharma veteran John Bonfiglio to board https://www.proactiveinvestors.com/companies/news/214890/genprex-adds-pharma-veteran-john-bonfiglio-to-board-214890.html Tue, 19 Feb 2019 14:39:00 -0500 https://www.proactiveinvestors.com/companies/news/214890/genprex-adds-pharma-veteran-john-bonfiglio-to-board-214890.html Eli Lilly’s $8B bet on Loxo is a ‘vote of confidence’ for novel scientific approaches that use DNA to treat cancer https://www.proactiveinvestors.com/companies/news/212091/eli-lillys-8b-bet-on-loxo-is-a-vote-of-confidence-for-novel-scientific-approaches-that-use-dna-to-treat-cancer-212091.html Mon, 07 Jan 2019 20:56:00 -0500 https://www.proactiveinvestors.com/companies/news/212091/eli-lillys-8b-bet-on-loxo-is-a-vote-of-confidence-for-novel-scientific-approaches-that-use-dna-to-treat-cancer-212091.html Genprex boosts outreach to investors with planned launch of corporate website https://www.proactiveinvestors.com/companies/news/211071/genprex-boosts-outreach-to-investors-with-planned-launch-of-corporate-website-211071.html Wed, 12 Dec 2018 14:45:00 -0500 https://www.proactiveinvestors.com/companies/news/211071/genprex-boosts-outreach-to-investors-with-planned-launch-of-corporate-website-211071.html Genprex, Aldevron report progress in clinical trials for lung-cancer therapy Oncoprex https://www.proactiveinvestors.com/companies/news/209605/genprex-aldevron-report-progress-in-clinical-trials-for-lung-cancer-therapy-oncoprex-209605.html Tue, 20 Nov 2018 15:41:00 -0500 https://www.proactiveinvestors.com/companies/news/209605/genprex-aldevron-report-progress-in-clinical-trials-for-lung-cancer-therapy-oncoprex-209605.html Genprex strengthens its team with new VP of clinical operations https://www.proactiveinvestors.com/companies/news/311186/genprex-strengthens-its-team-with-new-vp-of-clinical-operations-11186.html Tue, 13 Nov 2018 14:05:00 -0500 https://www.proactiveinvestors.com/companies/news/311186/genprex-strengthens-its-team-with-new-vp-of-clinical-operations-11186.html Genprex appoints new vice president of clinical operations https://www.proactiveinvestors.com/companies/news/208129/genprex-appoints-new-vice-president-of-clinical-operations-208129.html Tue, 30 Oct 2018 12:30:00 -0400 https://www.proactiveinvestors.com/companies/news/208129/genprex-appoints-new-vice-president-of-clinical-operations-208129.html How Genprex took an abandoned pipeline drug and turned it into Oncoprex, an innovative treatment for non-small cell lung cancer https://www.proactiveinvestors.com/companies/news/207017/how-genprex-took-an-abandoned-pipeline-drug-and-turned-it-into-oncoprex-an-innovative-treatment-for-non-small-cell-lung-cancer-207017.html Wed, 17 Oct 2018 19:30:00 -0400 https://www.proactiveinvestors.com/companies/news/207017/how-genprex-took-an-abandoned-pipeline-drug-and-turned-it-into-oncoprex-an-innovative-treatment-for-non-small-cell-lung-cancer-207017.html Genprex reaches deal with Aldevron for more plasmid DNA for expanding clinical program https://www.proactiveinvestors.com/companies/news/310720/genprex-reaches-deal-with-aldevron-for-more-plasmid-dna-for-expanding-clinical-program-10720.html Wed, 03 Oct 2018 16:45:00 -0400 https://www.proactiveinvestors.com/companies/news/310720/genprex-reaches-deal-with-aldevron-for-more-plasmid-dna-for-expanding-clinical-program-10720.html Genprex clinches deal with Aldevron to supply plasmid DNA for lung cancer-fighting therapy https://www.proactiveinvestors.com/companies/news/205888/genprex-clinches-deal-with-aldevron-to-supply-plasmid-dna-for-lung-cancer-fighting-therapy-205888.html Thu, 27 Sep 2018 13:40:00 -0400 https://www.proactiveinvestors.com/companies/news/205888/genprex-clinches-deal-with-aldevron-to-supply-plasmid-dna-for-lung-cancer-fighting-therapy-205888.html Genprex CEO updates investors on recent $10mln capital raise, progress of cancer-fighting drug Oncoprex https://www.proactiveinvestors.com/companies/news/310381/genprex-ceo-updates-investors-on-recent-10mln-capital-raise-progress-of-cancer-fighting-drug-oncoprex-10381.html Thu, 06 Sep 2018 15:40:00 -0400 https://www.proactiveinvestors.com/companies/news/310381/genprex-ceo-updates-investors-on-recent-10mln-capital-raise-progress-of-cancer-fighting-drug-oncoprex-10381.html Genprex licenses additional cancer-fighting technologies from University of Texas https://www.proactiveinvestors.com/companies/news/203716/genprex-licenses-additional-cancer-fighting-technologies-from-university-of-texas-203716.html Tue, 28 Aug 2018 18:00:00 -0400 https://www.proactiveinvestors.com/companies/news/203716/genprex-licenses-additional-cancer-fighting-technologies-from-university-of-texas-203716.html Genprex secures more capital to bring Oncoprex to market https://www.proactiveinvestors.com/companies/news/202971/genprex-secures-more-capital-to-bring-oncoprex-to-market-202971.html Wed, 15 Aug 2018 14:13:00 -0400 https://www.proactiveinvestors.com/companies/news/202971/genprex-secures-more-capital-to-bring-oncoprex-to-market-202971.html Genprex to enroll patients in study to evaluate anti-cancer agent Oncoprex with FDA-approved Erlotinib https://www.proactiveinvestors.com/companies/news/202128/genprex-to-enroll-patients-in-study-to-evaluate-anti-cancer-agent-oncoprex-with-fda-approved-erlotinib-202128.html Thu, 02 Aug 2018 14:55:00 -0400 https://www.proactiveinvestors.com/companies/news/202128/genprex-to-enroll-patients-in-study-to-evaluate-anti-cancer-agent-oncoprex-with-fda-approved-erlotinib-202128.html Genprex inks research pact with the University of Texas to study anti-cancer agent Oncoprex https://www.proactiveinvestors.com/companies/news/201663/genprex-inks-research-pact-with-the-university-of-texas-to-study-anti-cancer-agent-oncoprex-201663.html Thu, 26 Jul 2018 13:45:00 -0400 https://www.proactiveinvestors.com/companies/news/201663/genprex-inks-research-pact-with-the-university-of-texas-to-study-anti-cancer-agent-oncoprex-201663.html Genprex to present at the Singular Research Summer Solstice conference https://www.proactiveinvestors.com/companies/news/201146/genprex-to-present-at-the-singular-research-summer-solstice-conference-201146.html Thu, 19 Jul 2018 12:00:00 -0400 https://www.proactiveinvestors.com/companies/news/201146/genprex-to-present-at-the-singular-research-summer-solstice-conference-201146.html Genprex making strides to take cancer-fighting drug Oncoprex to FDA approval https://www.proactiveinvestors.com/companies/news/309582/genprex-making-strides-to-take-cancer-fighting-drug-oncoprex-to-fda-approval-9582.html Thu, 14 Jun 2018 13:56:00 -0400 https://www.proactiveinvestors.com/companies/news/309582/genprex-making-strides-to-take-cancer-fighting-drug-oncoprex-to-fda-approval-9582.html